Massachusetts Financial Services Co. MA raised its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 13.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,888 shares of the medical instruments supplier’s stock after buying an additional 217 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Becton, Dickinson and were worth $346,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in the stock. Cohen Lawrence B increased its position in Becton, Dickinson and by 39.1% in the first quarter. Cohen Lawrence B now owns 4,272 shares of the medical instruments supplier’s stock valued at $784,000 after buying an additional 1,200 shares in the last quarter. Rockland Trust Co. bought a new position in shares of Becton, Dickinson and during the first quarter worth about $307,000. Wells Fargo & Company MN increased its position in shares of Becton, Dickinson and by 1.2% in the first quarter. Wells Fargo & Company MN now owns 3,283,068 shares of the medical instruments supplier’s stock worth $602,246,000 after buying an additional 39,362 shares during the period. AMG National Trust Bank increased its position in shares of Becton, Dickinson and by 4.2% in the first quarter. AMG National Trust Bank now owns 9,880 shares of the medical instruments supplier’s stock worth $1,813,000 after buying an additional 401 shares during the period. Finally, Integrated Wealth Management increased its position in shares of Becton, Dickinson and by 3.4% in the first quarter. Integrated Wealth Management now owns 5,444 shares of the medical instruments supplier’s stock worth $999,000 after buying an additional 181 shares during the period. 75.57% of the stock is currently owned by institutional investors and hedge funds.
Becton, Dickinson and Company (BDX) traded down 0.574% during trading on Thursday, hitting $200.235. The stock had a trading volume of 350,374 shares. The firm has a market cap of $45.57 billion, a P/E ratio of 57.989 and a beta of 1.05. The company has a 50-day moving average of $199.47 and a 200 day moving average of $188.45. Becton, Dickinson and Company has a 52-week low of $161.29 and a 52-week high of $206.63.
Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.44 by $0.02. The business had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.06 billion. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The business’s quarterly revenue was down 5.1% on a year-over-year basis. During the same period in the prior year, the firm posted $2.35 earnings per share. On average, equities research analysts predict that Becton, Dickinson and Company will post $9.46 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 83.43%.
COPYRIGHT VIOLATION WARNING: “Massachusetts Financial Services Co. MA Acquires 217 Shares of Becton, Dickinson and Company (BDX)” was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://stocknewstimes.com/2017/08/17/massachusetts-financial-services-co-ma-buys-217-shares-of-becton-dickinson-and-company-bdx-updated-updated.html.
A number of brokerages have recently issued reports on BDX. Bank of America Corporation restated a “buy” rating and set a $225.00 price objective (up from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. BidaskClub upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating in a report on Monday. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 target price for the company in a report on Monday, July 17th. Cowen and Company reissued a “buy” rating and issued a $230.00 price objective on shares of Becton, Dickinson and in a research note on Monday. Finally, Barclays PLC reaffirmed an “equal weight” rating and set a $210.00 target price (up previously from $205.00) on shares of Becton, Dickinson and in a research report on Thursday, August 10th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Becton, Dickinson and currently has a consensus rating of “Buy” and a consensus target price of $195.79.
In other news, insider Thomas E. Polen, Jr. sold 5,971 shares of the business’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the sale, the insider now directly owns 12,861 shares of the company’s stock, valued at $2,538,890.01. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Jeffrey S. Sherman sold 28,765 shares of the business’s stock in a transaction on Thursday, May 25th. The shares were sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the sale, the vice president now directly owns 70,821 shares in the company, valued at $13,171,289.58. The disclosure for this sale can be found here. Insiders have sold 57,631 shares of company stock worth $11,112,178 over the last three months. Corporate insiders own 1.40% of the company’s stock.
About Becton, Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.
Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.
